Close

Notable Mergers and Acquisitions of the Day 07/11: (ARJ) (BTU)/(MT) (VRX)/(SNY) (SWC) Jul 11, 2011 10:05AM
UBS Maintains a 'Neutral' on Cephalon (CEPH); Distracted 1Q11 May 4, 2011 12:46PM
UBS maintains a 'Buy' on Valeant Pharmaceuticals (VRX); Increasing PT for CEPH Deal Apr 11, 2011 11:04AM
UPDATE - UBS Downgraded Cephalon (CEPH) to Neutral; Likely Some Upside To Offer price, but Not Material Mar 31, 2011 10:06AM
UBS Downgrades Cephalon (CEPH) to Neutral Mar 31, 2011 07:31AM


Feb 25, 2011 12:21PM UBS Maintains a 'Buy' on Valeant Pharmaceuticals (VRX); Everything’s Still Peachy Here
Feb 14, 2011 10:44AM Notable Analyst Rating Changes 02/14: EXPE, MTW, HERO, MXIM Upgraded; GME, WMT, CLX, NOK Downgraded
Jan 7, 2011 10:16AM UBS Maintains a 'Buy' on Valeant Pharmaceuticals (VRX); The Great Earnings Story Continues
Oct 11, 2010 09:19AM Daily State of the Markets 10/11: Has Goldilocks Returned?
Jun 22, 2010 10:39AM Notable Analyst Rating Changes 06/22: VRX, LNCR, MAT, ARBA Upgraded; BVF, BIG, WAG, NOV Downgraded
Jun 22, 2010 07:27AM Piper Jaffray Upgrades Valeant Pharmaceuticals (VRX) to Overweight; Compelling Cash Flow Story with Addition of BVF
Jun 21, 2010 01:08PM Unusual 11 Mid-Day Movers 06/21: EFJI, AIPC, UTSI, MELA, RADA, BVF Higher; AFFY, CYPB, ZIOP, FORD, PCBC Lower
Jun 21, 2010 12:58PM Biovail (BVF), Valeant Pharma (VRX) to Merge in Stock Deal; BVF Shares Up 11% Today
Jun 21, 2010 06:47AM Valeant (VRX) And Biovail (BVF) Announces Merger Agreement
Jun 9, 2009 09:40AM Notable Analyst Rating Changes 6/9: X, CSX, OMTR, MRVL Higher; HIG, VRX, MAS Lower